REGENXBIO Inc. (RGNX): Price and Financial Metrics
RGNX Price/Volume Stats
| Current price | $8.20 | 52-week high | $22.42 |
| Prev. close | $8.21 | 52-week low | $5.62 |
| Day low | $8.01 | Volume | 819,700 |
| Day high | $8.31 | Avg. volume | 993,800 |
| 50-day MA | $7.37 | Dividend yield | N/A |
| 200-day MA | $9.96 | Market Cap | 410.71M |
RGNX Stock Price Chart Interactive Chart >
REGENXBIO Inc. (RGNX) Company Bio
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.
RGNX Price Returns
| 1-mo | 22.02% |
| 3-mo | 10.66% |
| 6-mo | -24.07% |
| 1-year | -63.03% |
| 3-year | -74.42% |
| 5-year | -75.80% |
| YTD | 6.08% |
| 2024 | -56.94% |
| 2023 | -20.86% |
| 2022 | -30.64% |
| 2021 | -27.91% |
| 2020 | 10.72% |
Continue Researching RGNX
Want to do more research on REGENXBIO Inc's stock and its price? Try the links below:REGENXBIO Inc (RGNX) Stock Price | Nasdaq
REGENXBIO Inc (RGNX) Stock Quote, History and News - Yahoo Finance
REGENXBIO Inc (RGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...